Literature DB >> 34241771

Predicting HIV drug resistance using weighted machine learning method at target protein sequence-level.

Qihang Cai1, Rongao Yuan2, Jian He1, Menglong Li1, Yanzhi Guo3.   

Abstract

Acquired immune deficiency syndrome (AIDS) is a fatal disease caused by human immunodeficiency virus (HIV). Although 23 different drugs have been available, the treatment of AIDS remains challenging because the virus mutates very quickly which can lead to drug resistance. Therefore, predicting drug resistance before treatment is crucial for individual treatments. Here, based on HIV target protein sequence information, we analyzed 21-drug resistance caused by mutated residues using machine learning (ML) methods. To transform target sequences into numeric vectors, seven physicochemical properties were used, which can well represent the interacting characteristics of target proteins. Then, principal component analysis (PCA) method was adopted to reduce the feature dimensionality. Random forest (RF) and support vector machine (SVM) based on three different kernel functions, including linear, polynomial and radial basis function (RBF), were all employed. By comparisons, we found that RBF-based SVM method gives a comparative performance with RF model. Further, we added the weight information to RBF-based SVM method by four different weight evaluation methods of RF, eXtreme Gradient Boosting (XGB), CfsSubsetEval and ReliefFAttributeEval, respectively. Results show that the RF-weighted RBF-based SVM yield the superior performance and 13 out of 21 drug models provide the correlation coefficients (R2) over 0.8 and 3 of them are higher than 0.9. Finally, position-specific importance analysis indicates that most of the mutation residues with high RF weight scores are proved to be closely related with drug resistance, which has been revealed in previous reports. Overall, we can expect that this method can be a supplementary tool for predicting HIV drug resistance for newly discovered mutations. Here, based on HIV target protein sequence information, we analyzed 21-drug resistance caused by mutated residues using machine learning (ML) methods by fusing the weight information of different mutation positions.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  HIV drug resistance; Prediction; Target protein sequences; Weighted machine learning method

Mesh:

Substances:

Year:  2021        PMID: 34241771     DOI: 10.1007/s11030-021-10262-y

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   3.364


  15 in total

Review 1.  The causes and consequences of HIV evolution.

Authors:  Andrew Rambaut; David Posada; Keith A Crandall; Edward C Holmes
Journal:  Nat Rev Genet       Date:  2004-01       Impact factor: 53.242

2.  Geno2pheno: Estimating phenotypic drug resistance from HIV-1 genotypes.

Authors:  Niko Beerenwinkel; Martin Däumer; Mark Oette; Klaus Korn; Daniel Hoffmann; Rolf Kaiser; Thomas Lengauer; Joachim Selbig; Hauke Walter
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

3.  A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients.

Authors:  Kristel Van Laethem; Andrea De Luca; Andrea Antinori; Antonella Cingolani; Carlo Federico Perna; Anne-Mieke Vandamme
Journal:  Antivir Ther       Date:  2002-06

Review 4.  The origin of genetic diversity in HIV-1.

Authors:  Redmond P Smyth; Miles P Davenport; Johnson Mak
Journal:  Virus Res       Date:  2012-06-21       Impact factor: 3.303

5.  Multilabel classification for exploiting cross-resistance information in HIV-1 drug resistance prediction.

Authors:  Dominik Heider; Robin Senge; Weiwei Cheng; Eyke Hüllermeier
Journal:  Bioinformatics       Date:  2013-06-21       Impact factor: 6.937

6.  Genotypic predictors of human immunodeficiency virus type 1 drug resistance.

Authors:  Soo-Yon Rhee; Jonathan Taylor; Gauhar Wadhera; Asa Ben-Hur; Douglas L Brutlag; Robert W Shafer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-25       Impact factor: 11.205

7.  Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial.

Authors:  Jean-Luc Meynard; Muriel Vray; Laurence Morand-Joubert; Esther Race; Diane Descamps; Gilles Peytavin; Sophie Matheron; Claire Lamotte; Sonia Guiramand; Dominique Costagliola; Françoise Brun-Vézinet; François Clavel; Pierre-Marie Girard
Journal:  AIDS       Date:  2002-03-29       Impact factor: 4.177

Review 8.  Current perspectives on HIV-1 antiretroviral drug resistance.

Authors:  Pinar Iyidogan; Karen S Anderson
Journal:  Viruses       Date:  2014-10-24       Impact factor: 5.048

9.  Exploiting HIV-1 protease and reverse transcriptase cross-resistance information for improved drug resistance prediction by means of multi-label classification.

Authors:  Mona Riemenschneider; Robin Senge; Ursula Neumann; Eyke Hüllermeier; Dominik Heider
Journal:  BioData Min       Date:  2016-02-29       Impact factor: 2.522

10.  SHIVA - a web application for drug resistance and tropism testing in HIV.

Authors:  Mona Riemenschneider; Thomas Hummel; Dominik Heider
Journal:  BMC Bioinformatics       Date:  2016-08-22       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.